These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. T cell large granular lymphocyte leukemia and chronic NK lymphocytosis. Barilà G; Calabretto G; Teramo A; Vicenzetto C; Gasparini VR; Semenzato G; Zambello R Best Pract Res Clin Haematol; 2019 Sep; 32(3):207-216. PubMed ID: 31585621 [TBL] [Abstract][Full Text] [Related]
4. Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis. Gorodetskiy VR; Sidorova YV; Kupryshina NA; Vasilyev VI; Probatova NA; Ryzhikova NV; Sudarikov AB Rheumatol Int; 2021 Jan; 41(1):147-156. PubMed ID: 33280072 [TBL] [Abstract][Full Text] [Related]
5. Mixed-phenotype large granular lymphocytic leukemia: a rare subtype in the large granular lymphocytic leukemia spectrum. Neff JL; Rangan A; Jevremovic D; Nguyen PL; Chiu A; Go RS; Chen D; Morice WG; Shi M Hum Pathol; 2018 Nov; 81():96-104. PubMed ID: 29949739 [TBL] [Abstract][Full Text] [Related]
6. Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients. Barilà G; Teramo A; Calabretto G; Vicenzetto C; Gasparini VR; Pavan L; Leoncin M; Vedovato S; Frigo AC; Facco M; Semenzato G; Zambello R Leukemia; 2020 Apr; 34(4):1116-1124. PubMed ID: 31740810 [TBL] [Abstract][Full Text] [Related]
7. [Large Granular Lymphocytic Leukemia and JAK/STAT Signaling Pathway--Review]. Qiu ZY; Fan Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):254-60. PubMed ID: 26913432 [TBL] [Abstract][Full Text] [Related]
9. Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia. Teramo A; Barilà G; Calabretto G; Vicenzetto C; Gasparini VR; Semenzato G; Zambello R Front Oncol; 2020; 10():152. PubMed ID: 32133291 [TBL] [Abstract][Full Text] [Related]
10. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Jerez A; Clemente MJ; Makishima H; Koskela H; Leblanc F; Peng Ng K; Olson T; Przychodzen B; Afable M; Gomez-Segui I; Guinta K; Durkin L; Hsi ED; McGraw K; Zhang D; Wlodarski MW; Porkka K; Sekeres MA; List A; Mustjoki S; Loughran TP; Maciejewski JP Blood; 2012 Oct; 120(15):3048-57. PubMed ID: 22859607 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia. Bhattacharya D; Teramo A; Gasparini VR; Huuhtanen J; Kim D; Theodoropoulos J; Schiavoni G; Barilà G; Vicenzetto C; Calabretto G; Facco M; Kawakami T; Nakazawa H; Falini B; Tiacci E; Ishida F; Semenzato G; Kelkka T; Zambello R; Mustjoki S Blood Cancer J; 2022 Feb; 12(2):31. PubMed ID: 35210405 [TBL] [Abstract][Full Text] [Related]
12. STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia. Shi M; He R; Feldman AL; Viswanatha DS; Jevremovic D; Chen D; Morice WG Hum Pathol; 2018 Mar; 73():74-81. PubMed ID: 29288042 [TBL] [Abstract][Full Text] [Related]
13. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia. Rajala HL; Olson T; Clemente MJ; Lagström S; Ellonen P; Lundan T; Hamm DE; Zaman SA; Lopez Marti JM; Andersson EI; Jerez A; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S Haematologica; 2015 Jan; 100(1):91-9. PubMed ID: 25281507 [TBL] [Abstract][Full Text] [Related]
14. STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation. Kim D; Park G; Huuhtanen J; Ghimire B; Rajala H; Moriggl R; Chan WC; Kankainen M; Myllymäki M; Mustjoki S Leukemia; 2021 Dec; 35(12):3430-3443. PubMed ID: 34075200 [TBL] [Abstract][Full Text] [Related]
15. Discovery of Dysimmunity in Large Granular Lymphocytic Leukemia (LGLL) using Bioinformatic Analysis. Lu G; Du J; Mou W; Hu J; Han XL Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865255 [TBL] [Abstract][Full Text] [Related]
16. Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells. Pastoret C; Desmots F; Drillet G; Le Gallou S; Boulland ML; Thannberger A; Doncker AV; Salaun V; Damaj GL; Veyrat-Masson R; Tournilhac O; Moignet A; Pangault C; Roussel M; Fest T; Lamy T Blood; 2021 Jun; 137(23):3237-3250. PubMed ID: 33512451 [TBL] [Abstract][Full Text] [Related]
17. STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells. Kawakami T; Sekiguchi N; Kobayashi J; Yamane T; Nishina S; Sakai H; Hirabayashi Y; Nakazawa H; Ishida F Int J Hematol; 2019 May; 109(5):563-571. PubMed ID: 30859397 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes. Olson KC; Kulling Larkin PM; Signorelli R; Hamele CE; Olson TL; Conaway MR; Feith DJ; Loughran TP Cytokine; 2018 Nov; 111():551-562. PubMed ID: 30455079 [TBL] [Abstract][Full Text] [Related]
19. Mutations in the signal transducer and activator of transcription family of genes in cancer. Shahmarvand N; Nagy A; Shahryari J; Ohgami RS Cancer Sci; 2018 Apr; 109(4):926-933. PubMed ID: 29417693 [TBL] [Abstract][Full Text] [Related]
20. Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients. Barilà G; Grassi A; Cheon H; Teramo A; Calabretto G; Chahal J; Vicenzetto C; Almeida J; Shemo BC; Shi M; Gasparini VR; Munoz-Garcia N; Pastoret C; Nakazawa H; Oshimi K; Sokol L; Ishida F; Lamy T; Orfao A; Morice WG; Loughran TP; Semenzato G; Zambello R Blood; 2023 Mar; 141(9):1036-1046. PubMed ID: 36096473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]